Matthew Call

Chief Operating Officer, iTeos Therapeutics, Inc.

Companies

iTeos Therapeutics, Inc.Chief operating officer Jul 23, 2020 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

iTeos Therapeutics, Inc.0 shares²Aug 29, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 29, 2025U 161,898 shares of iTeos Therapeutics, Inc.²
Mar 7, 2025Granted 24,000 shares of iTeos Therapeutics, Inc.³
Dec 5, 2023Granted 44,000 shares of iTeos Therapeutics, Inc.⁴
Mar 28, 2023Exercised options 40,226 shares at $2.95 of iTeos Therapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARiTeos Therapeutics, Inc., Chief operating officer
2
SEC EDGARiTeos Therapeutics, Inc. shares after the filing of Aug 29, 2025
3
SEC EDGARForm 4 filed Mar 11, 2025
4
SEC EDGARForm 4 filed Dec 7, 2023
5
SEC EDGARForm 4 filed Mar 29, 2023